Direct comparison
Clinical Trial Monitor vs. Auditor
ICH E6(R2) compared: monitors (CRAs) do routine site oversight for clinical ops; auditors do independent, periodic QA reviews. Roles and reporting lines.
Side-by-side comparison
| Dimension | Monitor (CRA) | Auditor |
|---|---|---|
| Governing ICH E6(R2) provision | Section 1.38/1.39 (definition), Section 5.18 (monitoring requirements) | Section 1.6 (definition), Section 5.19 (audit requirements) |
| Primary purpose | Ongoing verification that the trial is conducted, recorded, and reported per protocol, SOPs, GCP, and applicable regulation | Independent, systematic evaluation of whether trial conduct and the sponsor's quality systems are sound |
| Reports to | Sponsor's clinical operations function | Sponsor's quality assurance (QA) function, structurally separate from clinical operations |
| Independence from trial conduct | Not independent — part of the routine operational oversight chain | Independent — not otherwise involved in the trial's routine conduct or monitoring |
| Frequency / timing | Recurring, scheduled per the trial's monitoring plan (e.g. Interim Monitoring Visits) | Periodic and risk-based; may also be ad hoc or "for cause" |
| Announced vs. unannounced | Scheduled and expected by the site | Can be announced or unannounced |
| Core method | Source Data Verification (SDV) against source documents, protocol-compliance checks | Systems- and process-level review of trial conduct, documentation, and quality controls |
| Typical output | Monitoring report to the sponsor after each visit (per Section 1.39) | Audit report/findings, often feeding a corrective and preventive action (CAPA) plan |
| Typical employer | Sponsor or contracted CRO (clinical operations) | Sponsor's internal QA unit or a contracted independent auditor/QA vendor |
| Relationship to regulatory inspection | Distinct from inspection; inspection is external and government-run (e.g. FDA BIMO) | Distinct from inspection but structurally closer to it — both are independent, systems-level reviews |
Common questions
FAQ
Can the same person be both a trial's monitor and its auditor?+
No, not on the same trial. ICH E6(R2) Section 5.19's audit requirement depends on the auditor being independent of, and not otherwise involved in, the routine conduct or monitoring of the trial being audited. A CRA who monitors a site cannot also serve as that site's independent auditor — doing so would defeat the purpose of the audit as a quality-assurance check on the monitoring function itself.
Do a monitor's visit and an audit look at the same documents?+
They can draw on the same underlying records — the Trial Master File, site regulatory binder, and source documents — but with different scope and intent. A monitor typically checks individual data points against source documents (source data verification) at each visit. An auditor evaluates whether the systems and processes producing that data, including the monitoring function itself, are functioning as designed.
What triggers a "for cause" audit?+
A for-cause audit is triggered by a specific concern rather than being part of the routine, risk-based audit schedule — for example, a pattern of protocol deviations, a data-integrity concern, a whistleblower report, or preparation for a pivotal regulatory submission where the sponsor wants independent assurance before filing.
Is an auditor the same as an FDA inspector?+
No. Both a sponsor's auditor and a regulatory inspector are independent of routine trial conduct, but an auditor is part of the sponsor's own quality assurance system, while a regulatory inspector works for a government authority (in the US, under FDA's Bioresearch Monitoring, or BIMO, program) and has statutory authority the sponsor's own auditor does not.
